Cellular Dynamics (ICEL)

[XenaLives]

Shelf offering doesn't seem to be a bad thing - found two biotechs that did very well after a shelf offering.

The company now has patents and people who want cells. Money spent wisely on increasing production capacity will make the stock go up.

ICEL also has a large short position that has not been able to make a graceful exit so IMO there is a market....

 
 Settlement Date	Short Interest	Avg Daily Share Volume	Days To Cover 
 8/15/2014	685,856	27,148	25.263592 
 7/31/2014	757,083	19,833	38.172894 
 7/15/2014	735,381	26,349	27.909257 
 6/30/2014	579,031	99,257	5.833654 
 6/13/2014	552,640	26,016	21.242312 
 5/30/2014	585,341	33,460	17.493754 
 5/15/2014	605,400	31,726	19.082141 
 4/30/2014	580,025	39,541	14.668951 
 4/15/2014	616,988	53,891	11.448813 
 3/31/2014	588,757	79,412	7.413955 
 3/14/2014	529,358	76,648	6.906351 
 2/28/2014	533,097	59,926	8.895922 
 2/14/2014	565,697	51,512	10.981849 
 1/31/2014	539,420	57,610	9.363305 
 1/15/2014	558,592	65,934	8.471987 
 12/31/2013	554,649	83,294	6.658931 
 12/13/2013	393,873	26,321	14.964211 
 11/29/2013	371,134	50,624	7.331187 
 11/15/2013	292,485	55,998	5.223133 
 10/31/2013	272,912	46,280	5.896975 
 10/15/2013	246,998	65,891	3.748585 
 9/30/2013	112,656	152,715	1.000000 
 9/13/2013	117,578	60,484	1.943952 
  
 Read more: http://www.nasdaq.com/symbol/icel/short-interest#ixzz3Cr7dbkPI